These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23920)

  • 21. [Effect of seleptin on the reproduction of the active avoidance reaction in rats].
    Pankova NB; Nikushkin EV; Chernov GS
    Biull Eksp Biol Med; 1998 Jul; 126(7):28-30. PubMed ID: 9777189
    [No Abstract]   [Full Text] [Related]  

  • 22. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
    Ninan I; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxone prevents and blocks the emergence of neuroleptic-mediated oral stereotypic behaviors.
    Pollock J; Kornetsky C
    Neuropsychopharmacology; 1991 Jun; 4(4):245-9. PubMed ID: 1678260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the butaclamol template in a search for antipsychotic agents with lessened side effects.
    Kukla MJ; Bloss JL; Brougham LR
    J Med Chem; 1979 Apr; 22(4):401-6. PubMed ID: 34721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissimilar effects of subchronic clozapine and haloperidol on operant lever pressing in C57BL/6J, BALB/cJ, and LP/J mice.
    McKerchar TL; Fowler SC
    Behav Pharmacol; 2005 Nov; 16(7):585-9. PubMed ID: 16170236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    J Psychiatr Res; 1978; 14(1-4):225-40. PubMed ID: 281530
    [No Abstract]   [Full Text] [Related]  

  • 28. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
    Heal DJ; Green AR; Buylaert WA
    Neuropharmacology; 1980 Jan; 19(1):133-7. PubMed ID: 6102352
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of susceptibilities to the effects of antipsychotic drugs on lever-press avoidance responses between mice and rats.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1983 Dec; 33(6):1127-33. PubMed ID: 6142132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further evidence for the neuroleptic-like activity of gamma-endorphin.
    Király I; Tapfer M; Borsy J; Gráf L
    Peptides; 1981; 2(1):9-12. PubMed ID: 6165979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity.
    Wang L; Alachkar A; Sanathara N; Belluzzi JD; Wang Z; Civelli O
    Int J Neuropsychopharmacol; 2015 May; 18(12):. PubMed ID: 25991655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
    Ellefson CR; Woo CM; Miller A; Kehr JR
    J Med Chem; 1978 Sep; 21(9):952-7. PubMed ID: 31487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the conditiond avoidance behaviour of rats following the administration of drugs to the amygdala [proceedings].
    Dawes P; Redfern PH
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():36P. PubMed ID: 12311
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of apomorphine on operant behavior in rats under normoxic and hypoxic conditions.
    Sakurai I; Sato T; Yoshioka T; Nakamura A
    Aviat Space Environ Med; 1991 Nov; 62(11):1050-3. PubMed ID: 1741718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of neuroleptics upon repeated administration.
    Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
    Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
    Voith K; Bruderlein FT; Humber LG
    J Med Chem; 1978 Jul; 21(7):694-8. PubMed ID: 27637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats.
    Dettmar PW; Cowan A; Walter DS
    Neuropharmacology; 1978 Dec; 17(12):1041-4. PubMed ID: 570648
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of naloxone on a quickly learned conditioned suppression in rats following cessation of chronic haloperidol treatment.
    Kameyama T; Nagasaka M
    Brain Res; 1983 Sep; 275(2):389-91. PubMed ID: 6626989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of naloxone, chlorpromazine, and haloperidol pretreatment on levallorphan-induced disruption of rats' operant behaviour.
    Wray SR; Cowan A
    Psychopharmacologia; 1971; 22(3):261-70. PubMed ID: 5132008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.